Cholesterol-adjusted vitamin e serum levels are associated with cardiovascular events in patients with non-valvular atrial fibrillation

International Journal of Cardiology

Volumn 168, Issue 4, 2013, Pages 3241-3247

  Cangemi, Roberto ^a   Pignatelli, Pasquale ^a   Carnevale, Roberto ^a   Corazza, Gino Roberto ^b   Pastori, Daniele ^a   Farcomeni, Alessio ^a   Basili, Stefania ^a   Davì, Giovanni ^c   Ferro, Domenico ^a   Hiatt, William R ^d   Licata, Giuseppe ^e   Lip, Gregory Y H ^f   Loffredo, Lorenzo ^a   Mannucci, Pier Mannuccio ^g   Vestri, Annarita ^a   Violi, Francesco ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b UNIVERSITY OF PAVIA   (Italy)

^c UNIVERSITY OF CHIETI   (Italy)

^d UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

^e UNIVERSITY OF PALERMO   (Italy)

^f UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^g FONDAZIONE IRCCS CA GRANDA OSPEDALE MAGGIORE POLICLINICO   (Italy)

Author keywords

Atrial fibrillation; Cardiovascular events; Vitamin E

Indexed keywords

ALPHA TOCOPHEROL; ANTIARRHYTHMIC AGENT; ANTICOAGULANT AGENT; ANTITHROMBOCYTIC AGENT; CHOLESTEROL; CREATININE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; ISOPROSTANE DERIVATIVE; LOW DENSITY LIPOPROTEIN CHOLESTEROL; WARFARIN;

ADULT; AGE; AGED; ARTICLE; BRAIN ISCHEMIA; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CEREBROVASCULAR ACCIDENT; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; CORRELATION COEFFICIENT; CREATININE CLEARANCE; DIABETES MELLITUS; DISEASE ASSOCIATION; DISEASE DURATION; DISEASE SEVERITY; FATALITY; FEMALE; FOLLOW UP; HEART ATRIUM FIBRILLATION; HEART DEATH; HEART INFARCTION; HIGH RISK PATIENT; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MEDICAL HISTORY; METABOLIC SYNDROME X; NONFATAL MYOCARDIAL INFARCTION; NONVALVULAR ATRIAL FIBRILLATION; OXIDATIVE STRESS; PREDICTION; PRIORITY JOURNAL; PROPORTIONAL HAZARDS MODEL; PROSPECTIVE STUDY; SEX; SMOKING HABIT; SURVIVAL; UNIVARIATE ANALYSIS; URINARY EXCRETION; VALVULAR HEART DISEASE; VITAMIN BLOOD LEVEL;

ATRIAL FIBRILLATION; CARDIOVASCULAR EVENTS; VITAMIN E;

AGED; AGED, 80 AND OVER; ATRIAL FIBRILLATION; BIOLOGICAL MARKERS; CHOLESTEROL; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; VITAMIN E;

EID: 84886296418     PISSN: 01675273     EISSN: 18741754     Source Type: Journal    
DOI: 10.1016/j.ijcard.2013.04.142     Document Type: Article

References (41)

1. G.Y. Lip, R.G. Hart, and D.S. Conway Antithrombotic therapy for atrial fibrillation BMJ 325 2002 1022 1025
2. L. Polimeni, L. Perri, M. Saliola, S. Basili, and F. Violi The risk of myocardial infarction in patients with atrial fibrillation: an unresolved issue Intern Emerg Med 5 2010 91 94
3. B.F. Gage, A.D. Waterman, W. Shannon, M. Boechler, M.W. Rich, and M.J. Radford Validation of clinical classification schemes for predicting stroke: results from the National Registry of Atrial Fibrillation JAMA 285 2001 2864 2870
4. G.Y.H. Lip, R. Nieuwlaat, R. Pisters, D.A. Lane, and H.J.G.M. Crijns Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: The Euro Heart Survey on Atrial Fibrillation Chest 137 2009 263 272
5. J. Hermida, F.L. Lopez, R. Montes, K. Matsushita, B.C. Astor, and A. Alonso Usefulness of high-sensitivity C-reactive protein to predict mortality in patients with atrial fibrillation (from the Atherosclerosis Risk In Communities [ARIC] Study) Am J Cardiol 109 2012 95 99
6. G.Y. Lip, J.V. Patel, E. Hughes, and R.G. Hart High-sensitivity C-reactive protein and soluble CD40 ligand as indices of inflammation and platelet activation in 880 patients with nonvalvular atrial fibrillation: relationship to stroke risk factors, stroke risk stratification schema, and prognosis Stroke 38 2007 1229 1237
7. Z. Hijazi, J. Oldgren, and U. Andersson Cardiac biomarkers are associated with an increased risk of stroke and death in patients with atrial fibrillation: a Randomized Evaluation of Long-term Anticoagulation Therapy (RE-LY) substudy Circulation 125 2012 1605 1616
8. J.P. Piccini, S.R. Stevens, and Y. Chang Renal dysfunction as a predictor of stroke and systemic embolism in patients with nonvalvular atrial fibrillation: validation of the R2CHADS2 index in the ROCKET AF (rivaroxaban once-daily, oral, direct factor Xa inhibition compared with vitamin K antagonism for prevention of stroke and embolism trial in atrial fibrillation) and ATRIA (AnTicoagulation and risk factors in atrial fibrillation) study cohorts Circulation 127 2013 224 232
9. F. Violi, and L. Loffredo Thromboembolism or atherothromboembolism in atrial fibrillation? Circ Arrhythm Electrophysiol 5 2012 1053 1055
10. J. Frank, H. Weiser, and H.K. Biesalski Interaction of vitamins E and K: effect of high dietary vitamin E on phylloquinone activity in chicks Int J Vitam Nutr Res 67 1997 242 247
11. S.L. Booth, I. Golly, and J.M. Sacheck Effect of vitamin E supplementation on vitamin K status in adults with normal coagulation status Am J Clin Nutr 80 2004 143 148
12. A. Azzi Molecular mechanism of alpha-tocopherol action Free Radic Biol Med 43 2007 16 21
13. D. Ferro, P. Franciosa, and R. Cangemi Serum levels of vitamin E are associated with early recurrence of atrial fibrillation after electric cardioversion Circ Arrhythm Electrophysiol 5 2012 327 333
14. D.E. Singer, G.W. Albers, and J.E. Dalen Antithrombotic therapy in atrial fibrillation: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition) Chest 133 2008 546S 592S
15. D.W. Cockcroft, and M.H. Gault Prediction of creatinine clearance from serum creatinine Nephron 16 1976 31 41
16. B. Williams The year in hypertension J Am Coll Cardiol 48 2006 1698 1711
17. R.B. D'Agostino Sr., R.S. Vasan, and M.J. Pencina General cardiovascular risk profile for use in primary care: the Framingham Heart Study Circulation 117 2008 743 753
18. S.M. Grundy, H.B. Brewer Jr., J.I. Cleeman, S.C. Smith Jr., and C. Lenfant Definition of metabolic syndrome: report of the National Heart, Lung, and Blood Institute/American Heart Association conference on scientific issues related to definition Circulation 109 2004 433 438
19. K.G. Alberti, and P.Z. Zimmet Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation Diabet Med 15 1998 539 553
20. M. Jessup, W.T. Abraham, and D.E. Casey 2009 focused update: ACCF/AHA Guidelines for the Diagnosis and Management of Heart Failure in Adults: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines: developed in collaboration with the International Society for Heart and Lung Transplantation Circulation 119 2009 1977 2016
21. J.G. Bieri, T.J. Tolliver, and G.L. Catignani Simultaneous determination of alpha-tocopherol and retinol in plasma or red cells by high pressure liquid chromatography Am J Clin Nutr 32 1979 2143 2149
22. M.G. Traber, and I. Jialal Measurement of lipid-soluble vitamins - further adjustment needed? Lancet 355 2000 2013 2014
23. S. Basili, G. Tanzilli, and E. Mangieri Intravenous ascorbic acid infusion improves myocardial perfusion grade during elective percutaneous coronary intervention relationship with oxidative stress markers JACC Cardiovasc Interv 3 2010 221 229
24. A. Mezzetti, G. Zuliani, and F. Romano Vitamin E and lipid peroxide plasma levels predict the risk of cardiovascular events in a group of healthy very old people J Am Geriatr Soc 49 2001 533 537
25. C. Morocutti, G. Amabile, and F. Fattapposta Indobufen versus warfarin in the secondary prevention of major vascular events in nonrheumatic atrial fibrillation. SIFA (Studio Italiano Fibrillazione Atriale) Investigators Stroke 28 1997 1015 1021
26. E.J. Benjamin, R.B. D'Agostino, A.J. Belanger, P.A. Wolf, and D. Levy Left atrial size and the risk of stroke and death. The Framingham Heart Study Circulation 92 1995 835 841
27. F. Violi, and R. Cangemi Statin treatment as a confounding factor in human trials with vitamin E J Nutr 138 2008 1179 1181
28. M.J. Pencina, R.B. D'Agostino Sr., R.B. D'Agostino Jr., and R.S. Vasan Evaluating the added predictive ability of a new marker: from area under the ROC curve to reclassification and beyond Stat Med 27 2008 157 172 [discussion 207-12]
29. D. Pratico Prostanoid and isoprostanoid pathways in atherogenesis Atherosclerosis 201 2008 8 16
30. F. Violi, R. Cangemi, G. Sabatino, and P. Pignatelli Vitamin E for the treatment of cardiovascular disease: is there a future? Ann N Y Acad Sci 1031 2004 292 304
31. K.F. Gey, P. Puska, P. Jordan, and U.K. Moser Inverse correlation between plasma vitamin E and mortality from ischemic heart disease in cross-cultural epidemiology Am J Clin Nutr 53 1991 326S 334S
32. J. Ansell, J. Hollowell, V. Pengo, F. Martinez-Brotons, J. Caro, and L. Drouet Descriptive analysis of the process and quality of oral anticoagulation management in real-life practice in patients with chronic non-valvular atrial fibrillation: the international study of anticoagulation management (ISAM) J Thromb Thrombolysis 23 2007 83 91
33. S. Connolly, J. Pogue, and R. Hart Clopidogrel plus aspirin versus oral anticoagulation for atrial fibrillation in the Atrial fibrillation Clopidogrel Trial with Irbesartan for prevention of Vascular Events (ACTIVE W): a randomised controlled trial Lancet 367 2006 1903 1912
34. D. Ferro, S. Basili, D. Pratico, L. Iuliano, G.A. FitzGerald, and F. Violi Vitamin E reduces monocyte tissue factor expression in cirrhotic patients Blood 93 1999 2945 2950
35. R.J. Glynn, P.M. Ridker, S.Z. Goldhaber, R.Y. Zee, and J.E. Buring Effects of random allocation to vitamin E supplementation on the occurrence of venous thromboembolism: report from the Women's Health Study Circulation 116 2007 1497 1503
36. F. Violi, and P. Pignatelli Effects of random allocation to vitamin E supplementation on the occurrence of venous thromboembolism: report from the Women's Health Study Circulation 117 2008 e312-2
37. S.R. Thomas, S.B. Leichtweis, and K. Pettersson Dietary cosupplementation with vitamin E and coenzyme Q(10) inhibits atherosclerosis in apolipoprotein E gene knockout mice Arterioscler Thromb Vasc Biol 21 2001 585 593
38. R. Ricciarelli, J.M. Zingg, and A. Azzi Vitamin E reduces the uptake of oxidized LDL by inhibiting CD36 scavenger receptor expression in cultured aortic smooth muscle cells Circulation 102 2000 82 87
39. D. Pratico, R.K. Tangirala, D.J. Rader, J. Rokach, and G.A. FitzGerald Vitamin E suppresses isoprostane generation in vivo and reduces atherosclerosis in ApoE-deficient mice Nat Med 4 1998 1189 1192
40. F. Sofi, F. Cesari, R. Abbate, G.F. Gensini, and A. Casini Adherence to Mediterranean diet and health status: meta-analysis BMJ 337 2008 a1344
41. S. Kurl, M. Ala-Kopsala, and H. Ruskoaho Plasma N-terminal fragments of natriuretic peptides predict the risk of stroke and atrial fibrillation in men Heart 95 2009 1067 1071